[go: up one dir, main page]

DK3302435T3 - Liposomladning - Google Patents

Liposomladning Download PDF

Info

Publication number
DK3302435T3
DK3302435T3 DK16800705.2T DK16800705T DK3302435T3 DK 3302435 T3 DK3302435 T3 DK 3302435T3 DK 16800705 T DK16800705 T DK 16800705T DK 3302435 T3 DK3302435 T3 DK 3302435T3
Authority
DK
Denmark
Prior art keywords
lipo
recharging
lipo recharging
Prior art date
Application number
DK16800705.2T
Other languages
English (en)
Inventor
Timothy D Heath
Lisa Ann Krugner-Higby
Amy Lautenbach
Original Assignee
Plumb Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plumb Pharmaceuticals Inc filed Critical Plumb Pharmaceuticals Inc
Application granted granted Critical
Publication of DK3302435T3 publication Critical patent/DK3302435T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y10S977/907—Liposome

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK16800705.2T 2015-05-26 2016-05-26 Liposomladning DK3302435T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562166223P 2015-05-26 2015-05-26
US201662291225P 2016-02-04 2016-02-04
PCT/US2016/034305 WO2016191547A1 (en) 2015-05-26 2016-05-26 Liposome loading

Publications (1)

Publication Number Publication Date
DK3302435T3 true DK3302435T3 (da) 2023-06-06

Family

ID=57393076

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16800705.2T DK3302435T3 (da) 2015-05-26 2016-05-26 Liposomladning

Country Status (6)

Country Link
US (4) US9931298B2 (da)
EP (2) EP3302435B1 (da)
CA (1) CA3024951A1 (da)
DK (1) DK3302435T3 (da)
HK (1) HK1255538A1 (da)
WO (1) WO2016191547A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3302435B1 (en) * 2015-05-26 2023-03-08 Plumb Pharmaceuticals, Inc. Liposome loading
US10456360B2 (en) 2015-10-16 2019-10-29 Ipsen Biopharm Ltd. Stabilizing camptothecin pharmaceutical compositions
CN110496103B (zh) * 2018-05-18 2022-05-10 上海维洱生物医药科技有限公司 一种多西他赛棕榈酸酯脂质体及其制备方法
US20220054455A1 (en) * 2018-09-13 2022-02-24 Taiwan Liposome Co., Ltd. Sustained-release pharmaceutical compositions comprising of a sedative drug and uses thereof
JP7477844B2 (ja) * 2018-10-17 2024-05-02 タイワン リポソーム カンパニー リミテッド 免疫調節剤を含む徐放性医薬組成物およびその使用
CN114401746A (zh) * 2019-08-12 2022-04-26 耶路撒冷希伯来大学伊森姆研究发展有限公司 包括鸦片拮抗剂组合的药学组合物及复合材料及其使用方法
CA3203987A1 (en) * 2020-12-30 2022-07-07 Lourdes Felix Biodegradable implant including naltrexone and cholesterol
CN116211868B (zh) * 2023-03-04 2024-02-13 济南市中心医院 一种头孢克肟抗生素片剂及其制备方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993754A (en) 1974-10-09 1976-11-23 The United States Of America As Represented By The United States Energy Research And Development Administration Liposome-encapsulated actinomycin for cancer chemotherapy
US4086257A (en) 1976-10-12 1978-04-25 Sears Barry D Phosphatidyl quaternary ammonium compounds
CH624011A5 (da) 1977-08-05 1981-07-15 Battelle Memorial Institute
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4522803A (en) 1983-02-04 1985-06-11 The Liposome Company, Inc. Stable plurilamellar vesicles, their preparation and use
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
US4588578A (en) 1983-08-08 1986-05-13 The Liposome Company, Inc. Lipid vesicles prepared in a monophase
US4737323A (en) 1986-02-13 1988-04-12 Liposome Technology, Inc. Liposome extrusion method
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5000887A (en) * 1988-05-17 1991-03-19 Liposome Technology, Inc. Preparation of uniform-size liposomes
US4935171A (en) 1989-01-27 1990-06-19 Vestar, Inc. Method for vesicle formation
EP1613284A2 (en) * 2003-02-11 2006-01-11 Neopharm, Inc. Manufacturing process for liposomal preparations
CN100427064C (zh) * 2003-04-16 2008-10-22 沈阳药科大学 一种制备脂质体的新方法
CA2928387A1 (en) * 2004-05-03 2005-11-17 Merrimack Pharmaceuticals, Inc. Drug delivery liposomes containing anionic polyols or anionic sugars
US7465590B1 (en) 2005-06-30 2008-12-16 Nanometrics Incorporated Measurement of a sample using multiple models
WO2007107304A2 (en) * 2006-03-17 2007-09-27 Novosom Ag An efficient method for loading amphoteric liposomes with nucleic acid active substances
WO2007049278A2 (en) * 2005-10-26 2007-05-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem A method for preparing liposomes and uses thereof
WO2007102888A2 (en) * 2005-10-28 2007-09-13 The Regents Of The University Of Colorado Methods of treating cancer with doxazolidine and prodrugs thereof
JP5322476B2 (ja) * 2008-03-31 2013-10-23 テルモ株式会社 リポソームの製造装置およびリポソームの製造方法
JP5801055B2 (ja) * 2008-08-01 2015-10-28 協和発酵キリン株式会社 標的遺伝子の発現を抑制する組成物
WO2010074172A1 (ja) 2008-12-24 2010-07-01 株式会社バイオメッドコア リポソームの製造方法ならびにコレステロール溶解方法
FR2943669B1 (fr) * 2009-03-24 2011-05-06 Sanofi Aventis Derives de nicotinamide,leur preparation et leur application en therapeutique
JP5337722B2 (ja) 2010-01-07 2013-11-06 ヤマハ発動機株式会社 船舶用推進制御装置および船舶
AU2012217685B2 (en) * 2011-02-15 2017-05-18 Merrimack Pharmaceuticals, Inc. Compositions and methods for delivering nucleic acid to a cell
US20140127287A1 (en) * 2011-05-11 2014-05-08 Wisconsin Alumni Research Foundation (Warf) Liposome-encapsulated hydrogels for use in a drug delivery system
WO2014047116A1 (en) * 2012-09-18 2014-03-27 Comfort Care For Animals Llc Encapsulating liposomes
SI3922241T1 (sl) * 2013-02-01 2024-03-29 Celator Pharmaceuticals, Inc. Daljinjsko nalaganje nizko vodo-topnih zdravil v liposome
EP3302435B1 (en) * 2015-05-26 2023-03-08 Plumb Pharmaceuticals, Inc. Liposome loading

Also Published As

Publication number Publication date
HK1255538A1 (zh) 2019-08-23
EP3302435A1 (en) 2018-04-11
US12059499B2 (en) 2024-08-13
US20250041223A1 (en) 2025-02-06
US20210361576A1 (en) 2021-11-25
CA3024951A1 (en) 2016-12-01
US20180200187A1 (en) 2018-07-19
WO2016191547A1 (en) 2016-12-01
US20160346205A1 (en) 2016-12-01
EP4212148A1 (en) 2023-07-19
US11000478B2 (en) 2021-05-11
US9931298B2 (en) 2018-04-03
EP3302435A4 (en) 2018-12-26
EP3302435B1 (en) 2023-03-08

Similar Documents

Publication Publication Date Title
DK3283625T3 (da) Nukleasemedieret genomeditering
DK3331869T3 (da) Muscarinagonister
DK3277719T3 (da) Polypeptider
DK3305788T3 (da) Janus-kinase-hæmmer
DK3331528T3 (da) Muskarinagonister
DK3360890T3 (da) Genterapi
DK3341303T3 (da) Blisterpakning
DK3326191T3 (da) Strømfordeler
EP3454445A4 (en) CHARGING APPARATUS
DK3331529T3 (da) Muskarinagonister
DK3310450T3 (da) Olie-vand-separator
EP3366930A4 (en) ACCUMULATOR
MA41127A (fr) Chaussure auto-extensible
DK3302435T3 (da) Liposomladning
DK3270930T3 (da) Præeklampsi
EP3364945C0 (en) SOLID FORMULATION
EP3398470A4 (en) SHOE
DE102015211786A8 (de) Stator
FR3039940B1 (fr) Capacite virtuelle
DK3292136T3 (da) Penicillin-g-acylaser
EP3079195A4 (en) SECONDARY BATTERY
DE112015006486A5 (de) Inkubationsrinne
DK3274482T3 (da) Stenborsknop
DK3318308T3 (da) Badmintonketsjer
DE112015005905A5 (de) Gurtschlossbringer